🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single arm, open-label, non-randomized and single-center phase II...
Status
Unknown
Location
Li Xu
Start Date
2020-08-01
Trial ID
NCT04454905
Treatments Being Tested
This is an open-label, single-center, single-arm, dose escalation and dose ...
Status
Terminated
Location
Asan Medical Center
Start Date
2018-10-01
Trial ID
NCT03707028
Treatments Being Tested
To evaluate the efficacy and immune microenvironment changes in advanced he...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-09-01
Trial ID
NCT07147101
Treatments Being Tested
This is an open-labeled, single-center, Phase I study to evaluate the safet...
Status
Completed
Location
Sarcoma Oncology Research Center
Start Date
2017-12-22
Trial ID
NCT03396211
A Trial to Evaluate the Efficacy and Safety of Camrelizumab Plus Rivocerani...
Status
Completed
Location
Zhongshan Hospital, Fudan University
Start Date
2022-09-01
Trial ID
NCT05367687
Treatments Being Tested
Adrenocortical carcinoma (ACC) is a rare aggressive malignant tumor. Accord...
Status
Recruiting
Location
West China Hospital
Start Date
2025-03-15
Trial ID
NCT06831175
Treatments Being Tested
This is a prospective, single-arm clinical study designed to evaluate the e...
Status
Not Yet Recruiting
Location
Affiliated Hospital of Guangdong Medical University
Start Date
2026-08-01
Trial ID
NCT07684040
Treatments Being Tested
This is a randomized, open-label, international, multi-center, phase III tr...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-10
Trial ID
NCT03764293
To investigate the efficacy of SHR-1701 combined with Rivoceranib, with or ...
Status
Recruiting
Location
Liaoning Provincial Cancer Hospital
Start Date
2026-01-01
Trial ID
NCT07311408
Treatments Being Tested
A study to evaluate efficacy and safety of transarterial chemoembolization ...
Status
Active Not Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2022-08-09
Trial ID
NCT05320692
Treatments Being Tested